Asceneuron Appoints Peter Van Vlasselaer as Chairman
Serial biotech entrepreneur joins leading small molecule tau modulation company
LAUSANNE, Switzerland and CAMBRIDGE, Ma., January 17, 2019 -- (Healthcare Sales & Marketing Network) -- Asceneuron, an emerging leader in the development of orally bioavail... Biopharmaceuticals, Neurology, Personnel Asceneuron, Progressive Supranuclear Palsy, tau pathology
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Brain | Marketing | Neurology | Pathology | Pharmaceuticals | Progressive Supranuclear Palsy | Switzerland Health